These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3591453)

  • 21. Recombinant lys-plasminogen given before, but not after, recombinant tissue-type plasminogen activator markedly improves coronary thrombolysis in dogs: relationship of thrombolytic efficacy with parameters of fibrinolysis.
    Chen LY; Nichols WW; Saldeen TG; Mehta JL
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):283-9. PubMed ID: 8720429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.
    Wright RA; Flapan AD; Alberti KG; Ludlam CA; Fox KA
    J Am Coll Cardiol; 1994 Jul; 24(1):67-73. PubMed ID: 8006284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
    Mueller HS; Forman SA; Menegus MA; Cohen LS; Knatterud GL; Braunwald E
    J Am Coll Cardiol; 1995 Oct; 26(4):900-7. PubMed ID: 7560615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.
    Glas-Greenwalt P; Hall JM; Panke TW; Kant KS; Allen CM; Pollak VE
    J Lab Clin Med; 1986 Nov; 108(5):415-22. PubMed ID: 2430036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.
    Volpi A; de Vita C; Franzosi MG; Geraci E; Maggioni AP; Mauri F; Negri E; Sontoro E; Tavazzi L; Tognoni G
    J Am Coll Cardiol; 1994 Sep; 24(3):608-15. PubMed ID: 8077528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of the fibrinolysis system].
    Himmelreich G; Riess H
    Dtsch Med Wochenschr; 1991 Mar; 116(11):426-30. PubMed ID: 1900466
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise.
    Estellés A; Tormo G; Aznar J; España F; Tormo V
    Thromb Res; 1985 Nov; 40(3):373-83. PubMed ID: 4082114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
    Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
    Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
    Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.
    Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M
    N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The extrinsic fibrinolytic system in survivors of myocardial infarction.
    Nilsson TK; Johnson O
    Thromb Res; 1987 Dec; 48(6):621-30. PubMed ID: 3124290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemostatic function in myocardial infarction.
    Hamsten A; Blombäck M; Wiman B; Svensson J; Szamosi A; de Faire U; Mettinger L
    Br Heart J; 1986 Jan; 55(1):58-66. PubMed ID: 3947483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.